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Abstract: Posidonia oceanica (L.) Delile is a Mediterranean-endemic angiosperm often described for its
great ecological importance. Despite evidence of a millennia-old relationship between P. oceanica and
humans, as well as traditional medicine applications, the potential benefits of P. oceanica for human
health have been documented only recently. This review aims to compile newly acquired knowledge
on P. oceanica bioactive properties that allow the scientific community to look at this plant as a
promising source of natural therapeutical products for human health. Experimental investigations
conducted in both in vitro cellular-based and in vivo animal models pave the way for new research
projects aiming at the development of alternative and complementary therapeutic strategies based
on P. oceanica against a wide range of pathological conditions.
Keywords: P. oceanica; angiosperm; marine natural products; seagrass; secondary metabolites;
phytochemicals
1. Introduction
Seagrasses are flowering and rhizomatous plants that grow only in marine environ-
ments and form extensive underwater meadows. They are categorized into four families
in the monocotyledonous order Alismatales: Cymodoceaceae, Hydrocharitaceae, Posido-
niaceae, and Zosteraceae. They are among the most valuable coastal ecosystems on the
planet in terms of the goods and services they provide [1,2].
Although often confused with algae, seagrasses are marine vascular plants deriving
from higher terrestrial plants that have secondarily colonized marine habitats. Hence,
they generally share most of their primary and secondary metabolism features with their
relatives of the Alismatales order living in terrestrial and freshwater habitats [3].
Five species of seagrasses populate the Mediterranean Sea, Posidonia oceanica (L.)
Delile, Cymodocea nodosa (Ucria), Zostera marina L., Zostera noltii Hornemann, and Halophila
stipulacea (Forsskål) Ascherson (non-indigenous species) [4].
P. oceanica, a member of the Posidoniaceae family, is the most important species of
seagrass for the Mediterranean Sea’s ecological coastal balance due to its widespread
distribution and abundance [5].
P. oceanica is a slow-growing marine phanerogam (>10 cm year−1), organized in roots,
rhizomes, and leaves [5,6].
Under favorable environmental conditions, P. oceanica colonizes vast underwater
areas, forming extensive meadows from the surface to 40 m depth (although it has been
recorded in particularly clear waters until 48 m depth), covering about 1.5% of the total
Mediterranean Sea surface [7–9].
P. oceanica meadows are a highly complex and well-structured ecosystem known for
their high biodiversity and great primary productivity, which is of paramount importance
for the health of the Mediterranean coasts [10,11].
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For this reason, in the last twenty years, P. oceanica has become one of the main
targets of the protection and management of the Mediterranean marine environment. It
has been included by the European Union’s Habitat Directive (92/43/CEE) among the
habitats of priority interest [7,12,13] and it is protected under the Bern and the Barcelona
Conventions, and other legislation at a national level. Moreover, the MFSD (2008/56/EC)
selected P. oceanica as representative species of the angiosperm quality elements for the
Mediterranean marine environment [14].
P. oceanica, in addition to its inestimable ecological value for the Mediterranean marine
environment, has been used in the past for other purposes in the construction, industrial,
and commercial sectors, as well as in the pharmacological field. Besides the knowledge
handed down over time, in the last few years, a growing body of evidence have rein-
forced the awareness of the beneficial properties of P. oceanica phytocomplex for human
health [15–20], thus enhancing the scientific community interest in P. oceanica as an unex-
plored resource of phytotherapeutic compounds.
This overview for the first time focuses on recent advances in determinations of
P. oceanica biological activities, in particular its potential health benefits.
2. Ecological Significance of P. oceanica Seagrass Ecosystem
In the Mediterranean Sea, the dominant endemic seagrass P. oceanica forms widespread
ecosystems with high levels of biodiversity and productivity [7,21,22]. Figure 1 summarized
a variety of ecologically and geologically important functions of P. oceanica [23–25].
Figure 1. Summary list of the ecological significance of P. oceanica seagrass.
P. oceanica is considered of paramount importance being a hot spot of biodiversity,
hosting about 20–25% of all species living in the Mediterranean Sea. Leaves and rhizomes
offer substrata suitable for settlement and growth of a number of sessile organisms that
form stratified assemblage guaranteeing the development of microniches for different
taxonomic groups. About one-hectare meadows can host up to 350 different species of
animals, residents, or migrants, thus offering shelter and nourishment to cephalopods,
bivalves, gastropods, echinoderms, tunicates, and fish, also of considerable economic
importance. The rich and diversified animal and plant community populating these
grasslands contributes to create a complex trophic network, highly efficient and productive,
capable of exporting energy to other systems [7,26]. Other studies have pointed out that
the leaves of P. oceanica are a rich source of biochemical components, major and essential
trace elements, making the seagrass of great nutritional value to marine organisms and an
essential role in the marine food chain [27].
P. oceanica seagrass produces a large amount of plant biomass, ranging between 400
and 2500 gDW/m2/y−1, with decreasing values as depth increases. The contribution
of the autotrophic epiphytes commonly associated with this plant raises these values
dramatically to 2000–3000 gDW/m2/y−1. Because of these characteristics, P. oceanica
meadows are regarded as one of the most productive of the Earth’s ecosystems [7,26].
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P. oceanica is known as “the lung of the Mediterranean” because it can emit up to 20 L
of oxygen per day per square meter of meadows, making it the most important source of
oxygen supplied by coastal waters [24,28].
P. oceanica ecosystem is also important in coastal dynamics, as it contrasts gradual silt-
ing, stabilizes sediment, protects the coastline from erosion through seabed consolidation,
and attenuates swells and waves through the oscillatory movement of its leaves [29,30].
The floating dead leaves of P. oceanica (massive in autumn) that reach the coast create
dense deposits along with other debris and deposits; when conditions allow, they can
consolidate and produce a very compact and strong structure called “banquettes”, which
are essential for protecting the coast from erosion [7,31,32].
Coastal areas are often characterized by environmental disturbances both due to
natural events and anthropological activities (overexploitation, physical modification,
nutrient and sediment pollution, introduction of non-native species, climate change), with
consequent impacts on the marine ecosystem [33].
Seagrass meadows are subjected to all the mentioned threats so that they are presently
experiencing a decline globally [34] and are among the most threatened ecosystems on
earth [35]. This is especially true for the Mediterranean, a semi-enclosed basin under
severe demographic, urban, and industrial pressures, and where climate change is having
a significant impact [36]. Global acidification has been clearly demonstrated to be a new
and concerning threat to the health of marine and terrestrial ecosystems. As a result,
several studies have been conducted to investigate the role of coastal vegetation in carbon
sequestration (Blue Carbon). P. oceanica has the most organic carbon stores that have been
documented [37] and can be considered an “outlier” within seagrass species. Under this
contest, the loss of P. oceanica meadows assumes greater importance.
Its regression may result in the erosion and rapid remineralization of the carbon-rich
soils stored beneath the canopy, in particular in exposed locations, thus releasing CO2.
Furthermore, in areas where P. oceanica dies and the leaf canopy disappears, the underlying
matte is no longer protected against erosion; dismantling of the matte will amplify the
remineralization process accelerating climate change effects in a similar way to fossil fuels.
For this reason, P. oceanica has long been used as an excellent biological indicator of the
vitality and dynamics of meadows and human influence on the marine environment [24,25,38,39].
Hence, P. oceanica is an essential resource for humans, but at the same time, it represents
a fragile ecosystem with recovery times in hundreds of years. Faced with the dramatic
threat of P. oceanica meadows regression, in the last few years, numerous environmental
projects have been carried out for transplanting and reforesting the seagrass in the seabed
to support the conservation of P. oceanica as one of the most precious and important habitats
for marine environment and humans.
In this context, a recent study has developed an efficient system for the regeneration of
P. oceanica seagrass by storing free cells at low temperatures and initiating cell encapsulation.
Cell encapsulation was the only successful method to acclimatize cells to salinity, preserve
artificial material for sowing, and obtain embryos. This system could help solve problems
related to the intractable nature of in vitro regeneration of marine phanerogams [40].
3. Historical and Traditional Medical Uses of P. oceanica
Even before discovering its enormous ecological value, archaeological and historical
evidence tells of a relationship lasting for millennia between humans and P. oceanica
seagrass.
Curiously, in the cave of Lazaret, in the French Maritime Alps, remains of leaves
were found dating back to the end of the Riss glaciation (over 100 thousand years ago),
presumably used as a bed by the occupants [41].
P. oceanica claims numerous traditional uses in human history in various commercial
and industrial sectors thanks to its innumerable properties (Figure 2). The first details
on P. oceanica use in human civilization date back to ancient Egypt, where the P. oceanica
egagropils (agglomerates of fairly spherical fibers from dead leaves of P. oceanica formed
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by hydrodynamics in shallow waters and then rejected on the beaches) were used for the
production of footwear [42,43].
Figure 2. Schematic list of traditional roles of P. oceanica seagrass in both the commercial, industrial,
and agricultural sectors (blue box) and in the medical field for the treatment of human health
disorders (yellow box).
Moreover, for centuries P. oceanica leaves were used by the Venetians to wrap and trans-
port their famous delicate glass, these leaves were in fact known as “Venetian straw” [44].
They were also used as packaging for ceramics and even for fresh fish sold in the markets.
Furthermore, at the beginning of the twentieth century, the coastal populations of northern
Africa (Egypt, Libya, Tunisia) exploited the biological characteristics of P. oceanica also in
the building sector by using dry leaves as roof coverings [45] and thermal insulation for
habitation [44]. P. oceanica also claims use in the agricultural field. Traditionally, P. oceanica
leaves were used as agricultural fertilizer to improve the characteristics of the soil, a use
which went for a long time by the farmer of the Mediterranean coast [46,47]. However,
in 2009, the biochemical and mineral content of P. oceanica was more thoroughly studied.
The P. oceanica mineral content, especially calcium (Ca, 3890.00 mg/100 g), phosphorus
(P, 930.00 mg/100 g), and sodium (Na, 2765.00 mg/100 g), was found to be significantly
higher than the allowable concentrations proposed in Compost Management Program
(2012) (Ca: 3000, P: 250 and Na: 1000 mg/100 g) [27,48], thus revising the traditional use of
P. oceanica as an organic fertilizer and/or compost.
In Tunisia, P. oceanica leaves were used as livestock bedding, still in use today thanks
to their antifungal and insect repellent properties. Considering the nutritional value of
P. oceanica leaves similar to that of fodder plants, they were also used as food supplements
for poultry and livestock [7]. Among other uses, P. oceanica was employed in the production
of paper in the late nineteenth century [49,50].
The material extracted from P. oceanica has also been used experimentally for other
industrial applications, such as for methane and nitrocellulose production [51]. Beyond
varied applications in human activities, P. oceanica seagrass has traditionally been used
also as a medical plant in the treatment of various human disorders (Figure 2). The first
information on the P. oceanica healing properties comes from ancient Egypt, where it was
supposedly used for sore throat and skin problems [52]. An old botany handbook of
Cazzuola also mentions P. oceanica as a popular pharmacopeia product [53]. It has also
been documented that P. oceanica leaves were used to treat inflammation and irritation, but
also as a remedy for acne, lower limb pain, and colitis [54]. On the other hand, the curious
use of P. oceanica as padding for cushions and mattresses dates back to the sixteenth century.
It is believed that this practice served to prevent respiratory infections and alleviate the
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conditions of people with tuberculosis. The use of P. oceanica leaves decoction as a natural
remedy for diabetes and hypertension by the inhabitants of the coastal areas of Western
Anatolia belongs to a more recent tradition [55].
Queen of the seas for 120 million years, P. oceanica has therefore proved to be a precious
ally for the care of human health.
4. Phytochemical Compounds of P. oceanica Leaves
Numerous characterization studies have shown that P. oceanica is a rich source of sec-
ondary metabolites (Table 1), mainly represented by phenolic compounds [56], essential in
plant self-protection from photosynthetic stress, reactive oxygen, anthropogenic pressures,
predators, and pathogens [57,58].
Chicoric acid is reported as the major constituent of P. oceanica leaves [15,59,60].
However, P. oceanica leaves also abound with caftaric, gentisic, chlorogenic, caffeic, ferulic,
cinnamic, gallic, and p-coumaric acids [15,19,56,59,61]. In addition, quercetin, myricetin,
kaempferol, and isorhamnetin are found in the diethyl layer of a hydrochloric acid solution
used for extraction from P. oceanica leaves, were the most represented secondary metabolites
belonging to the class of flavonoids [62,63].
Other phenolic derivatives were identified and quantified in P. oceanica leaves extracts, in-
cluding phloroglucinol, pyrocatechol, pyrogallol, vanillin aldehyde, 4-hydroxybenzaldehyde,
3,4-dihydroxybenzaldehyde, benzoic acid, p-hydroxybenzoic acid, p-anisic acid, vanillic acid,
syringic acid, proanthocyanidins, and calchones (as phloretin and phloridzin) [56,59,62,63].
The presence of long-chain fatty acids in P. oceanica seagrass is another distinguishing
feature. The lipid fraction of P. oceanica leaves extracts was discovered to be primarily
composed of palmitic, palmitoleic, oleic, and linoleic acids, as well as the phytosteroids
campesterol, stigmasterol, and β-sitosterol [64]. Polyphenol-derived lignin was discovered
to be present in all plant tissues [65].
Table 1. Structures and molecular formulas of major compounds isolated from P. oceanica leaves.
Compound Molecular Formula Structure References
Chicoric Acid C22H18O12
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In 2013, posidozinol, new sesquiterpene alcohol, was isolated from a chloroform
extract of P. oceanica leaves [66].
Scientific research in recent years h s shed light on the ability f the P. oceanica sec-
ondary m tabolites to exert biological prop rties effectively due t the synergistic action
of its phytochemical components. The most rec nt developments in the field of h rbal
medicine on the health-promoting properties and benefits that P. oceanica could provide are
listed and summarized below
5. P. oceanica Bioactive Properties: From Tradition to New Horizons
5.1. Antibacterial, Antifungal, and Antiviral Role
As early as 1989, Bernard an Pesando attributed to an extract of P. oceanica rhizomes
for the Mediterranean maritime flora anti-bacteria and anti-fungal properties [67]. Subse-
quent studies showed that extracts from P. oceanica leaves also had antibacterial activities
against both Gram-positives and Gram-negatives, with particular efficacy against P. aerug-
inosa and S. aureus [68]. P. oceanica has also shown antiviral capabilities, notably, in 2018
Farid et al. obtained that P. oceanica ball extracts inhibited H5N1 virus infection by 45% [69].
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In recent years, scientific research has shown increasing interest in identifying natural
compounds with antioxidant and antimicrobial activity with potential applications in
food science [70]. The current trend in food processing is focusing on the use of natural
compounds, which are considered safe alternatives to chemical additives [71,72]. The
exploration of new phytocompounds with these functional properties is a topic of great
current interest with human well-being as the main goal. In fact, some microorganisms can
have a negative impact on food quality, safety, and shelf life, and oxidative processes can
have an impact on food quality, affecting human health.
P. oceanica seagrass, as an antimicrobial and antioxidant agent, has piqued the scientific
community’s interest in its potential applications in food science. A number of studies
have looked into the potential applications of P. oceanica in the field of food preservation by
reducing and eliminating pathogens and spoilage microorganisms in food [73,74].
In 2017, a P. oceanica leaves extract was found to reduce microbial spoilage in fresh
peaches, particularly that caused by the Pseudomonas population, and so proposed for
use on fresh-cut fruit [73]. This discovery could pave the way for the use of novel natural
extracts on ready-to-eat vegetables, increasing the consumer appeal of these healthy foods.
The growing interest in P. oceanica extracts in the field of food science has prompted
researchers to develop more environmentally friendly alternative methods that avoid the
use of toxic solvents to optimize the processes of extracting phytochemical compounds from
P. oceanica leaves. Indeed, the use of a water-soluble extraction method has been shown
to more ecologically ensure the maintenance of P. oceanica biological properties, including
antioxidant, antifungal activities, especially against food-borne fungi—i.e., P. digitatum,
P. italicum, P. expansum, B. cinerea, G. candidum, and A. niger—and antiviral against feline
calicivirus and murine norovirus. Future investigations aim to maximize extraction yields
and antioxidant, antifungal, and antiviral properties of the extracts [74].
5.2. Insights into the Bioactivities of P. oceanica with Potential Human Health Applications
Comprehending the potential of the natural world to produce secondary metabolites
is remarkable in a wide range of fields, including drug discovery. With more than 70% of
the Earth’s surface, the marine environment is the largest terrestrial habitat and prolific
supplier of biologically active compounds because of its extraordinary biodiversity, which
is relatively unexplored compared to terrestrial environments.
The variety of bioactive marine compounds with great pharmaceutical potential is
unique, and their production is aided by the chemical and physical conditions of the
sea. Marine natural products with a wide range of biological activities have increasingly
attracted the attention of many researchers as a useful resource for developing drugs for
the management of human health [75].
Beyond its invaluable ecological and environmental significance, scientific research
in recent years has fueled interest in the hitherto unexplored phytochemical properties of
P. oceanica for potential pharmaceutical applications in human health.
Recent studies have shown that P. oceanica acts through a variety of mechanisms of
action, establishes molecular interactions, and triggers multiple signaling pathways. These
insights are schematized in Figure 3 and described in detail below.
The high content of phenolic compounds and their derivatives make P. oceanica leaves
a rich source of antioxidant molecules. Physiologically, P. oceanica exploits its ability to
stimulate the functionality of antioxidant enzymes as a defense mechanism against various
environmental pressures [76], including increasingly frequent and strong thermal stress in
the face of human-induced climate change [77] or stressful conditions such as competition
from invasive macroalgae [76,78], which strongly contribute to the phenomenon of seagrass
regression in the Mediterranean.
In scientific research, many natural products with antioxidant properties have found
applications in a wide range of fields, including biomedicine. The exploration of new
natural products with these functional properties is a topic of great current interest for
human well-being as the main focus.
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Figure 3. Scheme of the different modes of action of P. oceanica and possible therapeutic targets for
human health.
P. oceanica seagrass may find application in the prevention of cellular damage and
oxidative stress-related diseases, due to its antioxidant power. P. oceanica leaves extract, rich
in chicoric acid, was shown to have effects on human dermal fibroblast proliferation and
collagen production, as well as anti-melanogenic properties in the human melanoma cell
line MeWo and lipolytic properties in human subcutaneous preadipocytes; these properties
were attributable to its antioxidant power [15]. Therefore, the antioxidant activity of
P. oceanica extract may be associated with protection against wrinkle formation, skin aging,
unwanted hyperpigmentation, and cellulite, in which oxidative stress plays a crucial role.
The imbalance between the production of reactive oxygen species (ROS) and their
elimination by protective mechanisms often underlies oxidative damage and thus the onset
and progression of inflammatory diseases [79]. Under conditions of inflammation, the
uncontrolled production of ROS during the so-called “oxidative burst” is closely related to
the histolesivity of inflammation, which represents the “dark” side of the inflammatory
process associated with suffering cells and tissues. A P. oceanica leaves extract was shown to
decisively suppress the expression level of key inflammation-associated enzymes, namely
inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), impairing the pro-
duction of cell- and tissue-damaging metabolites, like nitric oxide (NO) as a precursor
of peroxynitrite, and generally the production of intracellular ROS in lipopolysaccharide
(LPS)-stimulated murine macrophages RAW264.7 [17]. The transcription factor nuclear
factor-B (NF–κB) regulates genes involved in inflammation and tumorigenesis [80]. One
possible mechanism by which P. oceanica exerts its anti-inflammatory activity is the inhibi-
tion of NF–κB activity. Vasarri et al. (2019) found that P. oceanica inhibited LPS-induced
NF–κB activation by preventing phosphorylation and nuclear translocation of the p65
subunit of NF–κB [17].
In the NF–κB signaling pathway, IκB is an inhibitory protein that binds to inactive
cytosolic NF–κB. Following a pro-inflammatory stimulus, IκB kinase (IKK) phosphory-
lates IκB, degrading it and allowing NF–κB to translocate into the nucleus. P. oceanica
has been shown to prevent nuclear translocation of NF–κB by restoring basal levels of
IκB. The anti-inflammatory activity afforded by P. oceanica also occurred by modulating
signaling pathways upstream of NF–κB pathway, i.e., mitogen-activated protein kinase
(MAPK)/extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase
(PI3K)/protein kinase B (AKT). Notably, P. oceanica inhibited LPS-induced activation of
ERK and AKT [17].
A further in vivo study on different models of acute inflammatory pain in CD-1
mice provides pharmacological evidence for the anti-inflammatory and analgesic role of a
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P. oceanica leaves extract. Acute oral administration of the extract has been shown to dose-
dependently inhibit both inflammation-induced hypersensitivity after intraplantar injection
of carrageenan and inflammatory pain induced by intraplantar injection of interleukin–
1β (IL–1β) or formalin or against the physiological pain threshold in naive animals [81].
P. oceanica also reduced tissue myeloperoxidase (MPO) activity and tissue concentrations of
inflammatory cytokines, such as tumor necrosis factor-α (TNF–α) and IL–1β [81].
Other in vitro bioactivity studies have described the ability of a P. oceanica leaves ex-
tract to inhibit the migration and invasiveness of tumor cells, such as human fibrosarcoma
HT1080 cells [19] and human neuroblastoma cells SHSY5Y [18]. This role has been related
to its ability to inhibit the expression and activity of metalloproteases 2 and 9 proteolytic
enzymes playing a key role in the processes of tumor metastasis by degrading the extracel-
lular matrix [19]. The molecular mechanisms associated with the anti-migratory effects in
cancer cells involve the activation of autophagy [16], a conserved evolutionary process that
mediates the degradation of cytoplasmic material [82].
Leri et al. (2018) suggested that the activation of autophagy afforded by P. oceanica
is due to the concomitant and reverse modulation of ERK and AKT signaling pathways
culminating in the inhibition of the mammalian target of rapamycin (mTOR), the master
regulator of autophagy [16]. The interaction between P. oceanica and the ERK and AKT
pathways provides possible explanations for many of the beneficial effects of P. oceanica.
Typically, the mode of action of anticancer drugs is based primarily on differential
toxicity and sensitivity of actively growing tumor cells compared with normal cells. The
reported ability of the P. oceanica phytocomplex to act against cell migration by a com-
pletely nontoxic mechanism makes it a promising reservoir of potent and safe molecules
that can defend against neoplasms, but also against other chronic pathophysiological pro-
cesses, such as neurodegeneration, inflammation, and skin aging, in whose progression
gelatinolytic activity is the hallmark [16,19].
Many natural products have demonstrated effective anticancer activities for many
years, resulting in valuable chemotherapeutic and cancer prevention agents [83]. However,
the reduced bioavailability of natural products, which is often due to their hydrophilic or
lipophilic nature, limits their use in anticancer therapy as well as the treatment of other
diseases [84].
Different nanosystems (e.g., liposomes, polymer nanocapsules, and dendrimers) are
designed to deliver drugs and are composed of materials that can mask the unfavorable
biopharmaceutical properties of the encapsulated molecule [84]. The use of these nano-
delivery systems can increase the in vivo stability and bioavailability of the delivered
natural products, but also improve their selective activity against cancer cells. In this
context, P. oceanica leaves extract has been found suitable for the use of nanotechnology.
Piazzini et al. (2019) demonstrated that the use of polymeric nanomicelles of Soluplus®,
a tri-block copolymer consisting of polyvinylcaprolactam-polyvinylacetate-polyethylene
glycol, to deliver the extract allowed both to increase the aqueous solubility of P. oceanica
phytocomplex and to improve its bioactivity in terms of inhibition of human neuroblastoma
SHSY5Y cell migration. The prolonged release of the extract from the nanomicelles could be
the factor responsible for the demonstrated biological enhancement of P. oceanica [18]. The
development of an appropriate delivery nanosystem of P. oceanica may offer an advanced
approach to improve the bioavailability and/or optimize the solubility and stability of
P. oceanica extract promoting its potential health benefits.
Treatment with medicinal plants is as old as mankind. Knowledge of the use of
medicinal plants is the result of many years of fighting disease, during which humans
learned to look for medicine in nature. Modern science has recognized the active action
of medicinal plants and has included a number of drugs of plant origin known to ancient
civilizations and used over millennia [85]. The use of P. oceanica seaweed as a medicinal
plant dates back to Mediterranean civilizations, which used it to treat a variety of human
health problems, as described above. P. oceanica leaves decoction was used as a natural
remedy for diabetes and hypertension by the people of western Anatolia [55]. In this
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regard, Gokce et al. (2008) demonstrated that oral administration of an extract of P. oceanica
in alloxan-induced diabetic rats strongly restored the activity of antioxidant enzymes
and decreased the process of lipid peroxidation, as well as reduced blood glucose [55].
The ramification between the antioxidant, vasoprotective, and hypoglycemic properties
of P. oceanica extract could provide therapeutic benefits in diabetes-related endothelial
dysfunction and oxidative damage.
Persistent hyperglycemia or uncontrolled diabetes has the potential to cause severe
complications; an unavoidable consequence of a long-lasting hyperglycemic state is in-
creased accumulation of advanced glycation end products (AGEs), a heterogeneous group
of products obtained from the nonenzymatic Maillard reaction between circulating macro-
molecules and free-reducing sugars. P. oceanica leaves extract has been shown to inhibit the
formation of AGEs in vitro [20]. The dual antidiabetic and anti-glycation role of P. oceanica
may help manage diabetes and prevent associated complications.
Overall, P. oceanica phytocomplex is indicated to the entire scientific community as
a reservoir of molecules potentially exploitable in various applications in human health
(Figure 4).
Figure 4. Schematic representation of the potential benefits of P. oceanica phytocomplex in human
health.
6. Conclusions
P. oceanica is a member of the Posidoniaceae family and the most important species of
the Mediterranean angiosperms.
The idea behind this review was to highlight that until recently researchers have
described the roles of this angiosperm linked to the sea environmental health, and only
indirectly to the health of humans as recipients of good environmental conditions. Despite
its ecological role, this overview of the bioactive properties of P. oceanica allows the scientific
community to consider this plant as a promising resource for human health.
In recent studies, P. oceanica—rich in secondary metabolites—has shown some impor-
tant roles such as antioxidant, anti-inflammatory, antidiabetic, anti-glycation properties,
and the ability to suppress cancer cell migration. It has also been shown that P. oceanica
can act as an activator of autophagy through interaction with specific signal transduction
pathways.
A future challenge should include studying the bioavailability of P. oceanica secondary
metabolites and thus the actual beneficial effects on human health to propose this an-
giosperm for potential pharmacological applications.
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